查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1617142

2030 年大麻二酚市場預測：按產品類型、來源、分銷管道、給藥途徑、應用、最終用戶和地區進行的全球分析

Cannabidiol Market Forecasts to 2030 - Global Analysis By Product Type, Source, Distribution Channel, Route of Administration, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球大麻二酚市場規模為 76 億美元，預計預測期內複合年成長率為 19.1%，到 2030 年將達到 218 億美元。

大麻二酚 (CBD) 是大麻植物（尤其是大麻）中發現的天然化合物。與具有精神作用的 THC 不同，CBD 不會讓你「興奮」。 CBD 因其潛在的治療特性（例如減輕焦慮、疼痛和發炎）而受到廣泛關注。 CBD 通常用於油、膠囊、食品和外用產品。由於大麻的法律地位不同，其使用和監管因國家而異，但研究仍在探索其對各種健康狀況的有效性。

根據國際設施管理協會（IMFA）的數據，2020年84%的店內業務受到疫情影響，其中食品服務佔最大佔有率。

合法化和更廣泛的接受

大麻二酚（CBD）的合法化和接受度在世界各地不斷增加，市場正在迅速擴大。隨著越來越多的國家和州接受 CBD 的潛在治療功效，消費者的需求也在成長。 CBD 現在廣泛應用於健康產品、護膚，甚至食品和飲料中。這種轉變，加上支持 CBD 安全和健康益處的科學研究，以及對其非精神活性特性的日益認知，正在推動行業更大的成長和創新。

缺乏標準化測試和品管

市場上缺乏標準化測試和品管給消費者帶來了重大風險。如果沒有一致的測試，產品功效、純度和安全性可能會有很大差異，導致不可靠的體驗和潛在的健康風險。農藥和重金屬等有害物質的污染也是一個問題。缺乏監管會損害消費者的信任，使品牌因產品品質不穩定而難以建立信任，並阻礙產業發展。

消費者對天然和有機產品的興趣日益濃厚

消費者對天然和有機產品日益成長的興趣正在對市場產生重大影響。隨著越來越多的人尋求與整體、永續生活方式一致的健康解決方案，有機大麻衍生的 CBD 產品越來越受歡迎。消費者優先考慮透明度、品質和生態友善性，這推動了對有機 CBD 油、食品和護膚的需求。這種向天然替代品的轉變，強調純度、健康益處和道德採購，正在推動市場成長。

誤解和偏見

對大麻二酚的誤解和污名阻礙了其廣泛的市場接受。儘管CBD無毒，但它經常被誤認為是大麻的精神作用，導致潛在消費者感到困惑和不願意。這種恥辱加上錯誤訊息，可能會阻礙人們探索 CBD 的治療功效。此外，律師有時對於制定明確的指導方針猶豫不決，這阻礙了監管的進展。

COVID-19 的影響：

COVID-19 大流行對市場產生了各種影響。由於消費者尋求增強免疫力和緩解壓力，對健康產品的需求激增，而供應鏈中斷和商店關閉阻礙了產品的供應。此外，經濟不確定性導致一些消費者優先考慮必需品，影響了 CBD 的銷售。然而，疫情期間電子商務的興起和心理健康意識的提高最終促進了市場的長期成長。

大麻衍生性商品預計將在預測期內成為最大的細分市場

由於消費者對天然健康產品的需求不斷增加，預計大麻衍生領域將在預測期內佔據最大的市場佔有率。大麻衍生的 CBD 以其潛在的健康益處而聞名，並用於多種應用，包括護膚、營養食品和疼痛管理。它在許多地區的合法化以及對其治療特性的認知不斷提高，正在推動市場擴張。因此，大麻衍生的 CBD 市場繼續吸引大量投資和創新。

預計醫療產業在預測期內複合年成長率最高

在外推期間，醫療保健產業預計將經歷最高的複合年成長率。 CBD 越來越被認為可以有效治療慢性疼痛、癲癇、焦慮和失眠等疾病。隨著越來越多的國家將 CBD 的醫療用途合法化，並且正在進行的臨床試驗支持其益處，市場有望實現顯著成長。隨著消費者尋求替代療法，對油、膠囊和酊劑等醫用 CBD 產品的需求持續成長。

比最大的地區

由於消費者對天然保健產品的需求不斷成長，預計北美地區在預測期內將佔據最大的市場佔有率。在美國和加拿大，圍繞 CBD 的法律體制已經發展，許多州和省將基於大麻的產品用於醫療和娛樂用途合法化。該市場也受到不斷成長的健康和自然療法趨勢的支持，這些趨勢吸引了廣泛的消費者並推動了對 CBD 產品的強勁需求。

複合年成長率最高的地區：

在健康趨勢、監管變化和技術進步的推動下，亞太地區預計將在預測期內實現最高的成長率。精神和神經系統疾病的盛行率正在增加，增加了對 CBD 作為治療選擇的需求。電子商務平台的興起使 CBD 企業能夠直接接觸消費者，從而在實體零售基礎設施完全到位之前更容易進入市場。

免費客製化服務：

訂閱此報告的客戶將收到以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球大麻二酚市場：依產品類型

  • 大麻二酚油
  • 大麻二酚膠囊和軟膠囊
  • 食用大麻二酚
  • 大麻二酚外用藥物
  • 大麻二酚化妝品
  • 其他產品類型

第6章 全球大麻二酚市場：依來源分類

  • 源自大麻
  • 大麻衍生

第7章全球大麻二酚市場：依分銷管道

  • 網路零售
  • 專賣店
  • 超級市場和大賣場
  • 藥局/藥局

第8章全球大麻二酚市場：依給藥途徑

  • 口服
  • 局部的
  • 經皮吸收貼片
  • 吸入

第9章全球大麻二酚市場：依應用分類

  • 健康與保健
  • 醫療保健
  • 化妝品/個人護理
  • 食品/飲料
  • 其他用途

第 10 章 全球大麻二酚市場：依最終使用者分類

  • 成人
  • 老年人口
  • 寵物
  • 運動員和健身愛好者
  • 其他最終用戶

第11章全球大麻二酚市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第12章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章 公司概況

  • Medical Marijuana, Inc.
  • High Tide, Inc.
  • Curaleaf Holdings
  • Trulieve Cannabis Corp.
  • Canopy Growth Corporation
  • Tilray Brands
  • Aurora Cannabis Inc.
  • Charlotte's Web Holdings, Inc.
  • GW Pharmaceuticals plc
  • Lazarus Naturals
  • Select CBD
  • Veritas Farms
  • HempFusion
  • CBDistillery
  • Plus Products
Product Code: SMRC28020

According to Stratistics MRC, the Global Cannabidiol Market is accounted for $7.6 billion in 2024 and is expected to reach $21.8 billion by 2030 growing at a CAGR of 19.1% during the forecast period. Cannabidiol (CBD) is a natural compound found in the cannabis plant, specifically in hemp. Unlike its psychoactive counterpart, THC, CBD does not produce a "high." It has gained significant attention for its potential therapeutic properties, such as reducing anxiety, pain, and inflammation. CBD is commonly used in oils, capsules, edibles, and topical products. Research is ongoing to explore its effectiveness for various health conditions, though its use and regulation vary by country due to differing legal statuses of cannabis.

According to the International Facility Management Association (IMFA), 84% of in-store operations were affected due to the pandemic, of which food services represented a significant share in 2020.

Market Dynamics:

Driver:

Increasing legalization and acceptance

The increasing legalization and acceptance of cannabidiol (CBD) across the globe is rapidly expanding its market. As more countries and states embrace CBD for its potential therapeutic benefits, consumer demand grows. CBD is now widely used in wellness products, skincare, and even food and beverages. This shift is driven by growing awareness of its non-psychoactive properties, coupled with scientific research supporting its safety and health benefits, fostering greater industry growth and innovation.

Restraint:

Lack of standardized testing and quality control

The lack of standardized testing and quality control in the market poses significant risks to consumers. Without consistent testing, products may vary widely in potency, purity, and safety, leading to unreliable experiences and potential health risks. Contamination with harmful substances, such as pesticides or heavy metals, is also a concern. This lack of regulation undermines consumer trust and hampers the growth of the industry, as inconsistent product quality makes it difficult for brands to build credibility.

Opportunity:

Growing consumer interest in natural and organic products

The growing consumer interest in natural and organic products has significantly influenced the market. As more people seek wellness solutions that align with holistic and sustainable lifestyles, CBD products derived from organic hemp are becoming increasingly popular. Consumers are prioritizing transparency, quality, and eco-friendly practices, driving demand for organic CBD oils, edibles, and skincare. This shift towards natural alternatives is fueling market growth, with an emphasis on purity, health benefits, and ethical sourcing.

Threat:

Misconceptions and stigma

Misconceptions and stigma surrounding cannabidiol continue to hinder its widespread acceptance in the market. Despite its non-intoxicating nature, CBD is often mistakenly associated with marijuana's psychoactive effects, causing confusion and reluctance among potential consumers. This stigma, coupled with misinformation, can discourage people from exploring its therapeutic benefits. Additionally, it impedes regulatory progress, as lawmakers may hesitate to establish clear guidelines.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the market. While demand for wellness products surged as consumers sought immunity-boosting and stress-relief solutions, supply chain disruptions and store closures hindered product availability. Additionally, economic uncertainty led some consumers to prioritize essential goods, affecting CBD sales. However, the rise of e-commerce and increased awareness of mental health during the pandemic ultimately contributed to long-term market growth.

The hemp-derived segment is expected to be the largest during the forecast period

The hemp-derived segment is expected to account for the largest market share during the projection period due to increasing consumer demand for natural wellness products. Hemp-derived CBD, known for its potential health benefits, is used in various applications such as skincare, dietary supplements, and pain management. Legalization in many regions, along with growing awareness about its therapeutic properties, has fueled market expansion. As a result, the hemp-derived CBD market continues to attract significant investment and innovation.

The medical segment is expected to have the highest CAGR during the forecast period

The medical segment is expected to have the highest CAGR during the extrapolated period. CBD is increasingly recognized for its effectiveness in treating conditions like chronic pain, epilepsy, anxiety, and insomnia. With more countries legalizing medical CBD and ongoing clinical trials supporting its benefits, the market is poised for significant growth. The demand for medical-grade CBD products, including oils, capsules, and tinctures, continues to rise among consumers seeking alternative treatments.

Region with largest share:

North America region is estimated to account for the largest market share during the forecast period driven by increasing consumer demand for natural wellness products. In the U.S. and Canada, the legal framework surrounding CBD has evolved, with many states and provinces legalizing cannabis-based products for medical and recreational use. The market is also supported by the growing trend of wellness and natural remedies, attracting a wide consumer base and fueling strong demand for CBD-infused products.

Region with highest CAGR:

Asia Pacific is expected to register the highest growth rate over the forecast period driven by health trends, regulatory changes, and technological advancements. There is a rising prevalence of mental disorders and neurological diseases, which is increasing the demand for CBD as a therapeutic option. The rise of e-commerce platforms allows CBD companies to reach consumers directly, facilitating market entry before physical retail infrastructures are fully developed.

Key players in the market

Some of the key players in Cannabidiol Market include Medical Marijuana, Inc., High Tide, Inc., Curaleaf Holdings, Trulieve Cannabis Corp., Canopy Growth Corporation, Tilray Brands, Aurora Cannabis Inc., Charlotte's Web Holdings, Inc., GW Pharmaceuticals plc, Lazarus Naturals, Select CBD, Veritas Farms, HempFusion, CBDistillery and Plus Products.

Key Developments:

In January 2024, Aurora Cannabis Inc., an American cannabis-based products manufacturing company, launched cannabis-infused ready-to-drink product produced by Vacay and Versus. The newly launched products are available in three different fruit flavors - Neon Rush, Strawberry Pineapple Tropical Fizz, and Pineapple Coconut Fizz.

In January 2023, Medical Marijuana, Inc.'s subsidiary HempMedsBrasil introduced two new full-spectrum cannabidiol products in Brazil, available in concentrations ranging from 3,000-6,000 mg and sizes of 30 mL and 60 mL.

Product Types Covered:

  • Cannabidiol Oil
  • Cannabidiol Capsules and Softgels
  • Cannabidiol Edibles
  • Cannabidiol Topicals
  • Cannabidiol Cosmetics
  • Other Product Types

Sources Covered:

  • Hemp-Derived
  • Marijuana-Derived

Distribution Channels Covered:

  • Online Retail
  • Specialty Stores
  • Supermarkets & Hypermarkets
  • Pharmacies & Drug Stores

Route of Administrations Covered:

  • Oral
  • Topical
  • Transdermal Patches
  • Inhalation

Applications Covered:

  • Health & Wellness
  • Medical
  • Cosmetics & Personal Care
  • Food & Beverages
  • Other Applications

End Users Covered:

  • Adults
  • Elderly Population
  • Pets
  • Athletes & Fitness Enthusiasts
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cannabidiol Market, By Product Type

  • 5.1 Introduction
  • 5.2 Cannabidiol Oil
  • 5.3 Cannabidiol Capsules and Softgels
  • 5.4 Cannabidiol Edibles
  • 5.5 Cannabidiol Topicals
  • 5.6 Cannabidiol Cosmetics
  • 5.7 Other Product Types

6 Global Cannabidiol Market, By Source

  • 6.1 Introduction
  • 6.2 Hemp-Derived
  • 6.3 Marijuana-Derived

7 Global Cannabidiol Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online Retail
  • 7.3 Specialty Stores
  • 7.4 Supermarkets & Hypermarkets
  • 7.5 Pharmacies & Drug Stores

8 Global Cannabidiol Market, By Route of Administration

  • 8.1 Introduction
  • 8.2 Oral
  • 8.3 Topical
  • 8.4 Transdermal Patches
  • 8.5 Inhalation

9 Global Cannabidiol Market, By Application

  • 9.1 Introduction
  • 9.2 Health & Wellness
  • 9.3 Medical
  • 9.4 Cosmetics & Personal Care
  • 9.5 Food & Beverages
  • 9.6 Other Applications

10 Global Cannabidiol Market, By End User

  • 10.1 Introduction
  • 10.2 Adults
  • 10.3 Elderly Population
  • 10.4 Pets
  • 10.5 Athletes & Fitness Enthusiasts
  • 10.6 Other End Users

11 Global Cannabidiol Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Medical Marijuana, Inc.
  • 13.2 High Tide, Inc.
  • 13.3 Curaleaf Holdings
  • 13.4 Trulieve Cannabis Corp.
  • 13.5 Canopy Growth Corporation
  • 13.6 Tilray Brands
  • 13.7 Aurora Cannabis Inc.
  • 13.8 Charlotte's Web Holdings, Inc.
  • 13.9 GW Pharmaceuticals plc
  • 13.10 Lazarus Naturals
  • 13.11 Select CBD
  • 13.12 Veritas Farms
  • 13.13 HempFusion
  • 13.14 CBDistillery
  • 13.15 Plus Products

List of Tables

  • Table 1 Global Cannabidiol Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Cannabidiol Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Cannabidiol Market Outlook, By Cannabidiol Oil (2022-2030) ($MN)
  • Table 4 Global Cannabidiol Market Outlook, By Cannabidiol Capsules and Softgels (2022-2030) ($MN)
  • Table 5 Global Cannabidiol Market Outlook, By Cannabidiol Edibles (2022-2030) ($MN)
  • Table 6 Global Cannabidiol Market Outlook, By Cannabidiol Topicals (2022-2030) ($MN)
  • Table 7 Global Cannabidiol Market Outlook, By Cannabidiol Cosmetics (2022-2030) ($MN)
  • Table 8 Global Cannabidiol Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 9 Global Cannabidiol Market Outlook, By Source (2022-2030) ($MN)
  • Table 10 Global Cannabidiol Market Outlook, By Hemp-Derived (2022-2030) ($MN)
  • Table 11 Global Cannabidiol Market Outlook, By Marijuana-Derived (2022-2030) ($MN)
  • Table 12 Global Cannabidiol Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 13 Global Cannabidiol Market Outlook, By Online Retail (2022-2030) ($MN)
  • Table 14 Global Cannabidiol Market Outlook, By Specialty Stores (2022-2030) ($MN)
  • Table 15 Global Cannabidiol Market Outlook, By Supermarkets & Hypermarkets (2022-2030) ($MN)
  • Table 16 Global Cannabidiol Market Outlook, By Pharmacies & Drug Stores (2022-2030) ($MN)
  • Table 17 Global Cannabidiol Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 18 Global Cannabidiol Market Outlook, By Oral (2022-2030) ($MN)
  • Table 19 Global Cannabidiol Market Outlook, By Topical (2022-2030) ($MN)
  • Table 20 Global Cannabidiol Market Outlook, By Transdermal Patches (2022-2030) ($MN)
  • Table 21 Global Cannabidiol Market Outlook, By Inhalation (2022-2030) ($MN)
  • Table 22 Global Cannabidiol Market Outlook, By Application (2022-2030) ($MN)
  • Table 23 Global Cannabidiol Market Outlook, By Health & Wellness (2022-2030) ($MN)
  • Table 24 Global Cannabidiol Market Outlook, By Medical (2022-2030) ($MN)
  • Table 25 Global Cannabidiol Market Outlook, By Cosmetics & Personal Care (2022-2030) ($MN)
  • Table 26 Global Cannabidiol Market Outlook, By Food & Beverages (2022-2030) ($MN)
  • Table 27 Global Cannabidiol Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 28 Global Cannabidiol Market Outlook, By End User (2022-2030) ($MN)
  • Table 29 Global Cannabidiol Market Outlook, By Adults (2022-2030) ($MN)
  • Table 30 Global Cannabidiol Market Outlook, By Elderly Population (2022-2030) ($MN)
  • Table 31 Global Cannabidiol Market Outlook, By Pets (2022-2030) ($MN)
  • Table 32 Global Cannabidiol Market Outlook, By Athletes & Fitness Enthusiasts (2022-2030) ($MN)
  • Table 33 Global Cannabidiol Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.